Wemade Introduces New Updates to ‘MIR4’
2.11.2021 06:15:00 EET | Business Wire | Press release
MMORPG ‘MIR4’, with over one million concurrent users, will experience a large-scale update on November 2nd. It will include a release of a new class, Arbalist - a crossbow fighter with extremely destructive powers – and the unveiling of the Class Change system. Additional content includes a huge field boss, Crimson Emperor Utukan, and a new growth system – Solitude Training. Furthermore, XDRACO items will be updated and the DSP (DRACO Staking Program) official service will be launched.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211101006046/en/
MMORPG ‘MIR4’, with over one million concurrent users, will experience a large-scale update. It will include a release of a new class, Arbalist, a crossbow fighter with extremely destructive powers and the unveiling of the Class Change system. Additional content includes a huge field boss, Crimson Emperor Utukan, and a new growth system, Solitude Training. Furthermore, XDRACO items will be updated and the DSP (DRACO Staking Program) official service will be launched. (Graphic: Business Wire)
'Arbalist' is the only long-range physical attack type class in ‘MIR4’. Arbalist demonstrates extreme destructive power and high levels of survivability using a crossbow combined with martial arts. Groups of monsters can also be hunted efficiently using powerful Area of Effect skills and players can enjoy a new gameplay style with a sniping component that is a new experience for ‘MIR4’ users.
The Class Change system can change an existing character’s class while maintaining growth stats. Players can change and choose between the five classes, including the new class, Arbalist, as well as Warrior, Sorcerer, Taoist, and Lancer. The huge field boss, Crimson Emperor Utukan, will also be released. Crimson Emperor Utukan appears every Friday at 11 PM in each region server’s time zone in Crimson Abaddon, located on the fourth floor of Snake Valley. Players who are successful in battle with the field boss will receive 50 treasure chests.
Solitude Training is a growth system that can strengthen the four Blood Vessels; Conception Vessel, Governing Vessel, Thoroughfare Vessel, and Girdle Vessel for players at level 70 and above. Blood Vessels can be strengthened up to Tier 10 by upgrading using energy and materials.
Additionally, XDRACO items marked with the DRACO emblem will be updated and DSP official service will begin. The XDRACO items can be obtained through in-game item drops and DSP, and can be traded through EXCHANGE BY DRACO. Players can deposit their DRACO to DSP and acquire XDRACO items through a draw. The probability of winning the item increases as the deposit amounts and period increases, and those who do not win the draw will be refunded 100% of the deposited DRACO.
From my battle, to our war! Visit the official site for more information on the coming updates.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211101006046/en/
Contact information
Press contact:
Wemade Co., Ltd. (112040: KOSDAQ)
Yeonghyun Lee, PR Manager
yeonghyun@wemade.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Jeito Capital Hits Record $1.2 Billion (€1 Billion) 1 Close for Jeito II Fund to Drive Breakthrough Therapeutic Innovation for Patients8.4.2026 09:15:00 EEST | Press release
Jeito Capital (“Jeito”), a global independent private equity fund dedicated to Biopharma, today announces the final closing of its second fund Jeito II, exceeding its target at $1.2billion (above €1billion)1,2, and marking a new major milestone for European Biopharma investment. With this new fund, Jeito has now tripled its assets under management to €1.6 billion, following the closing in 2021 of fund Jeito I at $630 million (€534 million) and reinforces its position as a leading fully independent European Biopharma investor. Jeito II will continue the strategy established with Jeito I: selectively identifying and backing 15 to 20 of the most promising clinical stage Biopharma companies, primarily in Europe, developing breakthrough therapies for severe diseases with high unmet medical needs and accelerating the development path and future market access. This fundraising allows Jeito to increase the average size of future investments in portfolio companies up to €150 million, thus drivi
Croma-Pharma Acquires Synocrom™ and Returns to Orthopaedics8.4.2026 08:00:00 EEST | Press release
Croma-Pharma is returning to the orthopaedics market with the reacquisition of Synocrom™, a hyaluronic acid product for the treatment of knee osteoarthritis. A strategic return built on proven heritage With the reacquisition of Synocrom™, Croma-Pharma is re-entering orthopaedics and further broadening its portfolio in a field with strong historical roots for the company. Until 2014, Croma was active in orthopaedics, with Synocrom™ serving as a key pillar of its offering. Synocrom™ is not a new name in the market. During the period in which Croma actively marketed the product, it became one of the leading hyaluronic acid brands in Europe and ranked among the top brands in its category. Its return therefore represents more than a portfolio expansion: it marks the continuation of a successful orthopaedic legacy and reconnects Croma with an important part of its history. The reintroduction of Synocrom™ also builds on Croma-Pharma’s long-standing expertise in the development and manufacturi
Murata Begins Mass Production of Seven Automotive MLCCs with World-leading Capacitance for Their Rated Voltage and Size, Supporting Stable Operation of In-vehicle Systems and Greater Design Flexibility8.4.2026 05:00:00 EEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has begun mass production of seven AEC-Q200-qualified multilayer ceramic capacitors (MLCCs) that achieve the world’s largest capacitance for a given rated voltage and size*, supporting stable operation of in-vehicle systems and greater design flexibility. Five parts in the GCM series are rated at 2.5-4 Vdc, targeting IC peripheral circuits in advanced driver assistance systems (ADAS) and autonomous driving (AD) applications. The remaining two MLCCs are rated at 25 Vdc for in-vehicle power line applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260407486750/en/ [Murata Manufacturing Co., Ltd.] Seven automotive MLCCs In recent years, as ADAS and AD technologies advance, the number and performance level of systems installed in vehicles have continued to increase. As a result, demand for higher capacitance low-voltage MLCCs used around ICs has grown to e
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)7.4.2026 23:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seven newly hired non-executive employees. The equity awards were granted on April 1, 2026 and consisted of options to purchase an aggregate of 117,445 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 55,875 shares. The options have an exercise price per share equal to $5.62, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted s
SLB OneSubsea and Subsea7 Sign Collaboration Agreement with PETRONAS Suriname7.4.2026 23:05:00 EEST | Press release
Global energy technology company SLB (NYSE: SLB) today announced the signing of a strategic collaboration agreement between PETRONAS Suriname E&P B.V. (“PETRONAS Suriname”), a subsidiary of PETRONAS and Subsea Integration Alliance, comprising SLB OneSubsea and Subsea7. This partnership aims to unlock resources in Suriname’s emerging frontier basin through innovative and cost-effective subsea solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260331210557/en/ SLB OneSubsea has signed a strategic collaboration agreement between PETRONAS Suriname E&P B.V. (“PETRONAS Suriname”), a subsidiary of PETRONAS and Subsea Integration Alliance, comprising SLB OneSubsea and Subsea7. This partnership aims to unlock resources in Suriname’s emerging frontier basin through innovative and cost-effective subsea solutions. The agreement establishes a long-term framework for collaboration across the project lifecycle. This approach enables
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom